Potential AI-Powered Heart Health Upgrade for Samsung Galaxy Watches and Galaxy Ring

Samsung is revolutionizing the way its wearables monitor heart health with a groundbreaking new patent. The tech giant is aiming to enhance its devices’ ability to detect irregular heart rates and signs of atrial fibrillation by translating PPG signals into ECG waveforms.

Currently, Samsung’s smartwatches, like the Galaxy Watch 5, can perform ECG scans, but they require user initiation, limiting the ability to gather continuous heart rate data. However, with this new patent, Samsung plans to seamlessly convert ongoing heart rate data into ECG data, providing a more comprehensive picture of the user’s heart health.

The patent also introduces a generative AI system that will establish a stronger correlation between heart rate rhythms and ECG data, known as a “first-order Markov relationship.” While there may be false positives in detecting AFib, Samsung will utilize AI to cross-reference the data and ensure accuracy.

Although this technology is still in the patent stage, it is speculated to be integrated into future Samsung wearables, such as the Galaxy Watch 7, Galaxy Watch 4, and the rumored Galaxy Watch Ultra. Additionally, the Samsung Galaxy Ring is expected to feature ECG functionality, potentially making it one of the first devices to utilize this innovative technology.

Samsung’s commitment to advancing heart health monitoring in wearables showcases its dedication to providing users with cutting-edge technology for a healthier lifestyle. Stay tuned for more updates on this exciting development in wearable technology.